Microneedle for treating vitiligo as well as preparation method and application thereof

A vitiligo and microneedle technology, applied in the directions of non-active ingredients medical preparations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of high systemic toxicity and low drug utilization rate, and achieve the inhibition of local immune response. , reduce the number of doses, and enhance the effect of the application

Active Publication Date: 2022-07-29
广州市皮肤病防治所
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology describes an improved way that tiny pins are used on the surface layers (epidermal or subcutanial) of humans' skullcap tissue during eye disease researches. These small pills have strong hydrogels made from materials like gelatin and polyethylene glycol, allowing them to penetrate into these areas while still being dissolved when delivered drugs. They then release their medicine slowly over time inside this area where they target specific parts of the body called nerves involved in vision loss. By doing this, scientists may study how diseases affect those nerve cells causing visual impairment.

Problems solved by technology

This patents discuss how current therapies target specific parts of certain genes involved in controlling melanin production. These techniques include gene transfer technology, phototherapy, lasers, ionizing radiation, chemophoresis, stem cell transplantations, and various combinations of these approaches like those described above. While each approach provides technical benefits over existing options, they all suffer from limitations related to efficacy and potential side effects caused by either single agents or multiple agents simultanously applied without sufficient consideration during patient selection based solely upon whether it should actually work effectively against the problem addressed in previous studies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microneedle for treating vitiligo as well as preparation method and application thereof
  • Microneedle for treating vitiligo as well as preparation method and application thereof
  • Microneedle for treating vitiligo as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] A hydrogel for the treatment of vitiligo.

[0061] The preparation method of the hydrogel is as follows.

[0062] 1. Preparation of methacrylylated dextran (DexMA).

[0063] Dissolve 1.0 g of dextran in 10 mL of dimethyl sulfoxide, then add 2.0 g of 4-dimethylaminopyridine, and stir at room temperature for 1 hour; add 3 mL of glycidyl methacrylate to the reaction solution, and stir at room temperature in the dark 48 hours; the reaction solution was collected, dialyzed with a cellulose dialysis bag with a molecular weight cut-off of 3500 for 3 days, and freeze-dried to obtain a product, methacryl dextran.

[0064] Second, the preparation of hydrogels.

[0065] A solution of methacrylylated dextran was prepared with ultrapure water, wherein the mass concentration of methacrylylated dextran was 30%. Add lithium phenyl-2,4,6-trimethylbenzoylphosphonate (LAP) with a concentration of 0.005g / mL to the above solution to make its mass concentration 0.2%, mix, and use 365nm or

Embodiment 2

[0067] A hydrogel for the treatment of vitiligo.

[0068] The preparation method of the hydrogel is as follows.

[0069] 1. Preparation of methacrylylated dextran (DexMA).

[0070] Dissolve 1.0 g of dextran in 10 mL of dimethyl sulfoxide, then add 2.0 g of 4-dimethylaminopyridine, and stir at room temperature for 1 hour; add 3 mL of glycidyl methacrylate to the reaction solution, and stir at room temperature in the dark 48 hours; the reaction solution was collected, dialyzed with a cellulose dialysis bag with a molecular weight cut-off of 3500 for 3 days, and freeze-dried to obtain a product, methacryl dextran.

[0071] 2. Preparation of host-guest supramolecular HGSM.

[0072] 1. Synthesis of the host molecule ethyl isocyanate modified β-cyclodextrin (β-Cd-AOI 2 ).

[0073] 5 g of β-cyclodextrin (β-CD) was completely dissolved in 50 mL of anhydrous dimethylformamide (DMF) under nitrogen atmosphere. Then, 2 mL of 2-isocyanate ethyl acrylate (AOI) was added dropwise to the mi

Embodiment 3

[0082] A hydrogel for the treatment of vitiligo.

[0083] The preparation method of the hydrogel is as follows.

[0084] 1. Preparation of methacrylylated dextran (DexMA).

[0085] Same as Example 2.

[0086] 2. Preparation of host-guest supramolecular HGSM.

[0087] Same as Example 2.

[0088] 3. Preparation of hydrogels.

[0089] A mixed solution of methacryl-glucan and HGSM is prepared with ultrapure water, wherein the mass concentration of methacryl-glucan is 30%, and the mass concentration of HGSM is 10%. Add lithium phenyl-2,4,6-trimethylbenzoylphosphonate (LAP) with a concentration of 0.005g / mL to the above mixed solution to make its mass concentration 0.2%, mix, and use 365nm or 405nm illumination , and the irradiation time is 10s-1min to obtain the hydrogel.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a microneedle for treating leucoderma as well as a preparation method and application thereof, and relates to the field of medical biological materials. The microneedle comprises hydrogel, a water-soluble substrate material and an active pharmaceutical ingredient, the active pharmaceutical ingredient is selected from at least one of the following raw materials: melanotropin, tofacitinib, tacrolimus, pimerolimus or ruxolitinib. According to the microneedle, hydrogel with high mechanical strength is adopted, the microneedle can pierce the cuticle, the hydrogel is insoluble in water, the prepared microneedle does not need a large amount of organic solvent, after the microneedle pierces the cuticle, the medicine for treating leucoderma is directly delivered to the epidermal layer and the corium layer through the diffusion effect, and the medicine application effect is enhanced; meanwhile, the substrate of the microneedle is made of a water-soluble substrate material, after the skin is punctured by the microneedle, water is absorbed, the tip of the microneedle and the substrate of the microneedle are automatically separated, and the tip which is insoluble in water is remained in the skin, so that active pharmaceutical ingredients attached to the microneedle are released in a long-acting manner, and the administration frequency is reduced.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 广州市皮肤病防治所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products